Diva Deleon
Pediatric Endocrinology · Philadelphia, PANPI 1154341063
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Zealand Pharma A/s accounts for 74.1% of it on its own, with 5 other manufacturers making up the rest. 2023 is the largest year on record at $18,013, more than ten times the $1,488 reported in 2019.
Across 20 payments — averaging $1072.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zealand Pharma A/s$16K
- Zealand Pharma US, Inc.$2K
- Soleno Therapeutics, Inc.$1K
- Modernatx, Inc.$1K
- Rhythm Pharmaceuticals, Inc.$805
- Novo Nordisk$73
Across 327 payments — averaging $14,848 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$3M
- Zealand Pharma A/s$1.7M
- Modernatx, Inc.$110K
What the payments were for
- Consulting fees$3,76018%
- Speaking & faculty fees$6,29829%
- Travel & lodging$10,71650%
- Food & beverage$6773%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zealand Pharma A/s | 10 | $15,896 |
| Zealand Pharma US, Inc. | 1 | $1,950 |
| Soleno Therapeutics, Inc. | 1 | $1,488 |
| Modernatx, Inc. | 5 | $1,239 |
| Rhythm Pharmaceuticals, Inc. | 2 | $805 |
| Novo Nordisk | 1 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEGALOGUE$1,950
- Diazoxide Choline Controlled Release (DCCR)$1,488
- Imcivree$483
How this compares
$21,450 in reported general payments places this provider in the 85th percentile of 80 pediatric endocrinology providers in Pennsylvania.
Other pediatric endocrinology in Philadelphia
- Michael LevinePhiladelphia$128K
- Craig AlterPhiladelphia$102K
- Judith RossPhiladelphia$75K
- Julia CrowleyPhiladelphia$75K
- Steven WilliPhiladelphia$34K
- Andrew BauerPhiladelphia$34K
- David WeberPhiladelphia$24K
- Andrew CalabriaPhiladelphia$20K
- Maria VogiatziPhiladelphia$16K
- Adda GrimbergPhiladelphia$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.